Abdominal Surgery in Patients with Midgut Carcinoid Tumors

References

• Thompson G B, van Heerden J A, Martin JK, Jr., Schutt A J, Ilstrup D M, Carney JA. Carcinoid tumor of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985; 98: 1054–62
   PubMed Web of Science ®Google Scholar
• Norheim I, Öberg K, Theodorsson-Norheim E, et al. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 1987; 206: 115–25
   PubMed Web of Science ®Google Scholar
• Moertel C G, Hanley JA. Combination chemotherapy trials in metastatic carcinoid tumors and the malignant carcinoid syndrome. Cancer Clin Trials 1979; 2: 327–34
   PubMedGoogle Scholar
• Chernicoff D, Bukowski R M, Groppe CW., Jr., Hawlett JS. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin. Cancer Treat Rep 1979; 63: 795–6
   PubMedGoogle Scholar
• Kvols L K, Buck M. Chemotherapy of metastatic carcinoid and islet cell tumors. A review. Am J Med 1987; 82: 77–83, (Suppl. 5B)
   PubMed Web of Science ®Google Scholar
• Öberg K, Norheim I, Lundqvist G, Wide L. Cytotoxic treatment in patients with malignant carcinoid tumors: Response to streptozotocin—alone or in combination with 5-FU. Acta Oncol 1987; 26: 429–32
   PubMed Web of Science ®Google Scholar
• Öberg K, Funa K, Aim G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumors and carcinoid syndrome. N Engl J Med 1983; 309: 129–33
   PubMed Web of Science ®Google Scholar
• Öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumors with human leukocyte interferon: Long-term results. Cancer Treat Rep 1986; 70: 1297–1304
   PubMedGoogle Scholar
• Thulin L, Samnegard H, Tyden G, Long D, Effendic S. Efficacy of somatostatin in a patient with carcinoid syndrome. Lancet 1978; 2: 43
   PubMed Web of Science ®Google Scholar
• Kvols L K, Moertel C G, O'Connell M J, Schutt A J, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
   PubMed Web of Science ®Google Scholar
• Makridis C, Öberg K, Juhlin C, et al. Surgical treatment of midgut carcinoid tumors. World J Surg 1990; 14: 377–85
   PubMed Web of Science ®Google Scholar
• McCarthy S M, Stark D D, Moss AA., Goldberg HI. Computed tomography of malignant carcinoid disease. J Comput Assist Tomogr 1984; 8: 846–50
   PubMed Web of Science ®Google Scholar
• Cockey B M, Fishman E K, Jones B, Siegelman SS. Computed tomography of abdominal carcinoid tumor. J Comput Assist Tomogr 1985; 9: 38–42
   PubMed Web of Science ®Google Scholar
• Goldstein H M, Miller M. Angiographic evaluation of carcinoid tumors of the small intestine: the value of epinephrine. Radiology 1975; 114: 23–8
   PubMed Web of Science ®Google Scholar
• Christensen S C, Stage J G, Henriksen FW. Angiography in the diagnosis of carcinoid syndrome. Scand J Gastroent 1979; 111–4, (Suppl. 53)
   PubMed Web of Science ®Google Scholar
• Siegel R S, Kuhns L R, Borlaza G S, McCormick T L, Simmons JL. Computed tomography and angiography in ileal carcinoid tumor and retractile mesenteritis. Radiology 1980; 134: 437–40
   PubMed Web of Science ®Google Scholar
• Moerlel CG., Suer WG, Dockerty MB, Baggenstoss AH. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14: 901–12
   PubMed Web of Science ®Google Scholar
• Eckhauser F E, Argenta L C, Strodel W E, et al. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 1981; 90: 720–8
   PubMed Web of Science ®Google Scholar
• Anthony P P, Drury R AB. Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol 1970; 23: 110–8
   PubMed Web of Science ®Google Scholar
• Warner T F, O'Reilly G, McLee GA. Mesenteric occlusive lesion and ileal carcinoids. Cancer 1979; 44: 758–62
   PubMed Web of Science ®Google Scholar
• Martin YK. Carcinoid syndrome. Common problems in endocrine surgery, J A van aHeerden. Year Book Med Publ Inc, Chicago 1989; 251–7
   Google Scholar
• Knowlessar O D, Law D H, Sleisinger MH. Malabsorption syndrome associated with metastatic carcinoid tumor. Am J Med 1959; 27: 673–7
   PubMed Web of Science ®Google Scholar
• Stroedel W E, Talpos G., Eckhauser F, Thompson N. Surgical therapy for small-bowel carcinoid tumors. Arch Surg 1983; 118: 391–7
   PubMedGoogle Scholar
• Gillett D J, Smith RC. Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion. Am J Surg 1974; 128: 95–9
   PubMed Web of Science ®Google Scholar
• Martin J K, Moertel C G, Adson M A, Schutt AJ. Surgical treatment of functioning metastatic carcinoid tumors. Arch Surg 1983; 118: 537–42
   PubMedGoogle Scholar
• Zeitels J, Naunheim K, Kaplan E L, Strauss F. Carcinoid tumors. A 37-year experience. Arch Surg 1982; 117: 732–9
   PubMedGoogle Scholar
• Nobin A, Mansson B, Lunderquist A. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour. Acta Oncol 1989; 28: 419–24
   PubMed Web of Science ®Google Scholar
• Funa K, Papanicolaou V, Juhlin C, et al. Expression of platelet-derived growth factor B-type receptors on stromal tissue cells in human carcinoid tumors. Cancer Res 1990; 50: 748–53
   PubMed Web of Science ®Google Scholar
• Marsh H M, Martin J K, Kvols L K, et al. Carcinoid crisis during anesthesia: Successful treatment with a somatostatin analogue. Anesthesiology 1987; 66: 89–91
   PubMed Web of Science ®Google Scholar